Antimalarial activity of ferrocenyl chalcones

Area of Science:

• Medicinal Chemistry
• Parasitology
• Organic Synthesis

Background:

• Malaria remains a significant global health challenge, driven by drug-resistant Plasmodium falciparum strains.
• Developing novel antimalarial agents is crucial to combatting drug resistance.
• Ferrocene-containing compounds have emerged as a promising class for drug discovery.

Purpose of the Study:

• To synthesize and evaluate a series of ferrocenyl chalcones for in vitro antimalarial activity.
• To identify potent compounds against a chloroquine-resistant strain of Plasmodium falciparum.
• To explore structure-activity relationships based on compound characteristics.

Main Methods:

• Synthesis of diverse ferrocenyl chalcone derivatives.
• In vitro testing of synthesized compounds against chloroquine-resistant Plasmodium falciparum.
• Determination of inhibitory concentrations (IC50) for active compounds.

Main Results:

• Two compounds, 1-(3-pyridyl)-3-ferrocenyl-2-propen-1-one (6) and 1-ferrocenyl-3-(4-nitrophenyl)-2-propen-1-one (28), exhibited significant antimalarial activity.
• Compound 6 showed an IC50 of 4.5 microM, and compound 28 showed an IC50 of 5.1 microM.
• Observed activity differences were not clearly correlated with compound size or lipophilicity.

Conclusions:

• Ferrocenyl chalcones represent a viable scaffold for developing new antimalarial drugs.
• Compounds 6 and 28 are lead candidates for further investigation against malaria.
• Further research is needed to elucidate the precise mechanisms and structure-activity relationships governing their efficacy.